Navigation Links
Medarex Announces 2008 Third Quarter Financial Results
Date:10/30/2008

plications for two separate antibodies generated by Medarex's UltiMAb(R) technology.

-- Announcing the receipt of a milestone payment from MedImmune, Inc. for initiation of a Phase 2a multi-dose clinical trial of MEDI-545, an anti-interferon-alpha HuMAb(TM) for systemic lupus erythematosis.

About Medarex

Medarex is a biopharmaceutical company focused on the discovery, development and potential commercialization of fully human antibody-based therapeutics to treat life-threatening and debilitating diseases, including cancer, inflammation, autoimmune disorders and infectious diseases. Medarex applies its UltiMAb(R) technology and product development and clinical manufacturing experience to generate, support and potentially commercialize a broad range of fully human antibody product candidates for itself and its partners. Over forty of these therapeutic product candidates derived from Medarex technology are in human clinical testing or have had INDs submitted for such trials, with the most advanced product candidates currently in Phase 3 clinical trials or the subject of regulatory applications for marketing authorization. Medarex is committed to building value by developing a diverse pipeline of antibody products to address the world's unmet healthcare needs. For more information about Medarex, visit its website at http://www.medarex.com.

Statement on Cautionary Factors

Except for the historical information presented herein, the statements relating to Medarex's investments and advances related to its products in this press release may constitute forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995, that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Statements that are not historical facts, includin
'/>"/>

SOURCE Medarex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Medarex to Present at Thomas Weisel Partners Healthcare Conference 2007
2. Medarex to Present at the Bear Stearns 20th Annual Healthcare Conference
3. Medarex Announces Extension of Broad Antibody Development Relationship with Centocor
4. Medarex to Present at the A.G. Edwards 2nd Annual Emerging Growth Conference
5. Medarex to Present at the UBS Global Life Sciences Conference
6. Medarex Announces Election of Marc Rubin as New Board Member
7. Medarex to Present at the 26th Annual JPMorgan Healthcare Conference
8. Medarex Announces Completion of Sale of Shares in Genmab A/S
9. Medarex to Announce 2007 Fourth Quarter and Year-End Financial Results on Tuesday, February 26, 2008
10. Medarex to Present at the Susquehanna Financial Group Healthcare Conference
11. Medarex Announces Presentations at Annual Meeting of the American Association for Cancer Research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...wire/--Reportlinker.comannouncesthatanewmarketrese...BioethanolMarketAnalysisandForecaststo2013 ,, ...hanol-Market-Analysis-and-Forecasts-to-2013.html ...2013 ,, Summary ,, Thereportprovidesdetail...ndtheBrazilbioethanolmarketinparticular.Italsohelp...
(Date:11/24/2009)...assador to also Visit Detroit , ...d Appia, French Ambassador for International Inves...e Agency, , , , ,What: Ambassador Appia is availa...ess initiatives adopted by France to further devel...r innovation and development., , ,When: Available ...
(Date:11/24/2009)...ember24/PRNewswire-FirstCall/--deCODE,genetics,Inc...icefrom,theNasdaqStockMarketthattradinginthecompan...ndaForm25-NSEwillbefiledwiththe,SecuritiesandExcha...romlistingonNasdaq,unlessthecompanyfilesanappealto...filedsuchanappeal,which,willstaythesuspensionandde...
(Date:11/24/2009)...swire-Asia/--NODPharmaceuticalsInc.announced,theUS...applicationfor,itsnano-particleoraldeliveryorNODte...proachtoincorporatepeptidesor,proteinsintobio-adhe...rwiseadministeredasinjections.NODtechnologyisaplat...rdrugssuchasinsulin,interferon,growthhormone,exen...
Breaking Biology Technology:Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3
... to aid drug discovery by allowing for the rapid ...eaction, ST. LOUIS, Oct. 7 Sigma-Aldrich (Nasdaq...an exclusive licensing,agreement with the Universi...Aldrich to offer research quantities of powerful n...ra coupling to researchers worldwide,( http://sigm...
...o focus on new patient data supporting the Ross he...rGraft processed human heart ...yoLife, Inc. (NYSE: CRY ), a,biomaterials, medica...today,that cardiovascular surgeons from around the... two-day surgical congress to be held at the Compa...
...tutes of Health, The Infectious Disease Research, ...h and Board of Advisors, SEATTLE, Oct. 7 The Lil...s first acquisition of compounds for further,devel...eements were reached,with Summit plc (LSE: SUMM) o...earch Foundation (MCRF) of Tokyo for two compounds...
Other Biology Technology:Sigma-Aldrich and the University of Illinois Offer New Boronic Acid Surrogates to Researchers Worldwide Through Licensing Agreement 2Sigma-Aldrich and the University of Illinois Offer New Boronic Acid Surrogates to Researchers Worldwide Through Licensing Agreement 3CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure 2CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure 3CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure 4Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline 2Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline 3Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline 4Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline 5
(Date:11/23/2009)...tion Society says that western lowland gorillas li... of the "mother lode" of more than 125,000 gorilla...reatened by growing humans activity in the region....forests adjacent to the southwest border of Lac Tl...that high densities of the great apes still exist ...
(Date:11/23/2009)...s "incontrovertible evidence" that the volcanic su...t 73,000 years ago deforested much of central Indi...s report. , The volcano ejected an estimated 800...ing a crater (now the world,s largest volcanic lak...ide. Ash from the event has been found in India, t...
(Date:11/23/2009)...DOE and USDA study concluded that 50 million U.S. ...ture could be converted from current uses to the p...s, from which biomass could be harvested for use a...ion of a perennial grass monoculture from which su...ly is expected to require nitrogen fertilizer. , ...
Breaking Biology News(10 mins):A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Switchgrass produces biomass efficiently 2Drug Might Restore Sense of Smell 51357 1Drug Might Restore Sense of Smell 51357 2Drug Might Restore Sense of Smell 51357 3Dove and Early Canada Goose Seasons to Begin Sept 1 3B Game Commission Posts Avian Influenza Information on Website 51354 1Dove and Early Canada Goose Seasons to Begin Sept 1 3B Game Commission Posts Avian Influenza Information on Website 51354 2Dove and Early Canada Goose Seasons to Begin Sept 1 3B Game Commission Posts Avian Influenza Information on Website 51354 3Dove and Early Canada Goose Seasons to Begin Sept 1 3B Game Commission Posts Avian Influenza Information on Website 51354 4Dove and Early Canada Goose Seasons to Begin Sept 1 3B Game Commission Posts Avian Influenza Information on Website 51354 5Dove and Early Canada Goose Seasons to Begin Sept 1 3B Game Commission Posts Avian Influenza Information on Website 51354 6Dove and Early Canada Goose Seasons to Begin Sept 1 3B Game Commission Posts Avian Influenza Information on Website 51354 7Cardinal Health Board of Directors Approves CareFusion Spinoff 51351 1Cardinal Health Board of Directors Approves CareFusion Spinoff 51351 2Cardinal Health Board of Directors Approves CareFusion Spinoff 51351 3Cardinal Health Board of Directors Approves CareFusion Spinoff 51351 4Cardinal Health Board of Directors Approves CareFusion Spinoff 51351 5Cardinal Health Board of Directors Approves CareFusion Spinoff 51351 6
...ientists at Johns Hopkins have discovered how taki...py resistance in a common form of lung cancer. , ...ct cells from environmental pollutants like cigare...rials and pumping them out of the cell. Another g...leansing process. But lung cancer cells sabotage ...
...e emergency treatment of drug-resistant infections... need to identify bacterial strains by growing the...ational Symposium & Exhibition in San Francisc...iotechnology company Accelr8, described a new lab-... for the most common cases of drug-resistant pneum...
...e humble fruit fly and a grant from the AICR ?the ...e helping a leading scientist in London identify p...f cancer. , In one of the first studies of its ki...udwig Institute for Cancer Research (LICR) is usin...tic system in which to identify genes that may imp...
Other Biology News:Key to lung cancer chemo resistance revealed 2Lab-on-a-chip could speed up treatment of drug-resistant pneumonia 2Lab-on-a-chip could speed up treatment of drug-resistant pneumonia 3Using nature's most primitive anti-viral defense system to find new approaches to cancer research 2
...an aqueous-based mounting medium designed for the ...ns. Gel/Mount is especially recommended when using...lophycocyanin or FluoroBlue. It can also be used w...escein (FITC), Rhodamine (TMRITC) and Texas Red. G...
... medium is specifically formulated for mounting ti...ave been stained with immunohistochemical methods ...se with chromogens, such as AEC, that are alcohol-...amount dries completely when slides are cover-slip...
RNAsin from BD Biosciences Pharmingen
Mastercycler gradient from Eppendorf North America
Biology Products: